Indoco Remedies approves ₹0.20 dividend, higher borrowing limits at AGM
- Final dividend of ₹0.20 per equity share approved for FY26
- Shareholders authorized increased borrowing limits and asset sales
- Ms. Aditi Panandikar re-appointed as Managing Director
- Dr. Vasudha Kamat continues as independent director beyond age 75
*this image is generated using AI for illustrative purposes only.
Indoco Remedies shareholders approved a final dividend of ₹0.20 per equity share for FY26 during the company’s 79th annual general meeting held on September 17, 2026.
The meeting, conducted via video conferencing, also saw the approval of special resolutions to increase borrowing limits and authorize asset sales under Section 180 of the Companies Act, 2013.
Key Resolutions Passed
The board presented several ordinary and special business items for shareholder consideration. All resolutions were approved by the members present.
| Resolution Type | Key Items Approved |
|---|---|
| Ordinary Business | Adoption of standalone and consolidated financial statements for FY26 |
| Ordinary Business | Declaration of final dividend of ₹0.20 per share |
| Ordinary Business | Re-appointment of Ms. Aditi Panandikar as director |
| Special Business | Ratification of cost auditor remuneration for FY27 |
| Special Business | Re-appointment of Ms. Aditi Panandikar as Managing Director |
| Special Business | Continuation of Dr. Vasudha Kamat as independent director past age 75 |
| Special Business | Increase in borrowing limits under Section 180(1)(c) |
| Special Business | Approval to sell or mortgage assets under Section 180(1)(a) |
Leadership and Governance
Ms. Aditi Panandikar, Managing Director, addressed members on the company’s performance and future prospects. The board approved her re-appointment as both director and managing director.
Dr. Vasudha Kamat will continue as a non-executive independent director after completing 75 years of age, subject to regulatory compliance.
Meeting Details
The AGM commenced at 10:30 am and concluded at 11:48 am. Mr. Suresh G Kare, Chairman, presided over the proceedings. E-voting remained open for an additional 30 minutes post-meeting via MUFG Intime India Private Limited.
Voting results and the scrutinizer’s report will be filed with the exchanges in due course, as per SEBI regulations.
Historical Stock Returns for Indoco Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.13% | +10.01% | +15.86% | +34.48% | -16.53% | -46.66% |
How will the approved increase in borrowing limits impact Indoco Remedies' debt-to-equity ratio and future capital expenditure plans?
What specific assets are likely to be sold or mortgaged under the new Section 180 authorization, and how might this affect the company's operational capacity?
Given the modest final dividend of ₹0.20, does this signal a strategic shift towards retaining earnings for growth rather than shareholder payouts?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
